Clinical Trials in Women's Health

Historically, women have been underrepresented in clinical research, leading to critical data gaps and treatment biases. Clinical trials in women's health emphasizes the importance of inclusive study designs that account for sex-specific physiology, hormonal cycles, and disease expression. By focusing on diverse female populations—across age, ethnicity, and reproductive status—new trials are generating insights into gynecologic cancers, autoimmune disorders, menopause management, and more. Advances in trial design, including decentralized platforms and adaptive protocols, are helping researchers enroll and retain women more effectively. Ethical considerations around informed consent, reproductive safety, and equitable access are also being redefined to ensure integrity and inclusivity. Clinical trials in women's health are essential not only for drug and device development but for correcting long-standing imbalances in evidence-based care for women.